Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Jul;16(7):1043-1051.
doi: 10.2215/CJN.19181220. Epub 2021 May 26.

Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood

Affiliations
Multicenter Study

Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood

Marta Calatroni et al. Clin J Am Soc Nephrol. 2021 Jul.

Erratum in

Abstract

Background and objectives: ANCA-associated vasculitis is extremely rare in children. We report the clinicopathologic features, long-term outcomes, and prognostic factors of a large pediatric cohort of patients with ANCA-associated kidney vasculitis.

Design, setting, participants, & measurements: This retrospective study included 85 consecutive patients with kidney biopsy specimen-proven ANCA-associated vasculitis from tertiary referral centers in Italy and Canada. Kidney biopsy specimens were categorized as focal, crescentic, sclerotic, or mixed, according to the Berden classification. The prognostic significance of baseline clinical, laboratory, and histologic findings was analyzed with respect to kidney failure or CKD stage 3-5/kidney failure.

Results: A total of 53 patients had microscopic polyangiitis (62%), and 32 had granulomatosis with polyangiitis (38%). Rapidly progressive GN was the most frequent presentation (39%); a third of the patients also had nephrotic-range proteinuria. Kidney biopsy specimens were classified as focal in 21% of the patients, crescentic in 51%, sclerotic in 15%, and mixed in 13%. Remission-induction therapies included cyclophosphamide in 78% of patients. A total of 25 patients (29%) reached kidney failure. The median (interquartile range) time to kidney failure or last follow-up was 35 (6-89) months in the whole cohort, and 73 (24-109) months among the patients who did not reach this outcome. Patients whose biopsy specimens showed sclerotic histology had significantly shorter kidney survival (hazard ratio, 11.80; 95% confidence interval, 2.49 to 55.99) and survival free of CKD stage 3-5 (hazard ratio, 8.88; 95% confidence interval, 2.43 to 32.48), as compared with those with focal/mixed histology. Baseline eGFR, low serum albumin, hypertension, central nervous system complications, and sclerotic histology, which reflected severe kidney involvement, were associated with both kidney failure and CKD stage 3-5/kidney failure at unadjusted analysis; no independent prognostic factors emerged at multivariable analysis.

Conclusions: Children with ANCA-associated kidney vasculitis often have aggressive presentation; a third of such children progress to kidney failure and this usually occurs early during follow-up. A severe clinical presentation is associated with the development of CKD or kidney failure.

Keywords: ANCA; antineutrophil cytoplasmic antibody; glomerulopathy; pediatric nephrology; vasculitis.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Kidney survival analyses. (A) Kaplan–Meier curves of the time from diagnosis to kidney failure or last follow-up (“kidney survival”) in patients with different kidney histologic classes. (B) Kaplan–Meier curves of the time from diagnosis to CKD stage 3–5/kidney failure in patients with different kidney histologic classes. The plots also report hazard ratios (HR) from unadjusted Cox regression models. Ref., reference category.
Figure 2.
Figure 2.
CKD stages at last follow-up in the different histologic classes. Proportions of CKD stages at last follow-up in patients with different kidney histologic classes.

References

    1. Chaigne B, Guillevin L: Vasculitis for the internist: Focus on ANCA-associated vasculitis. Intern Emerg Med 12: 577–585, 2017 - PubMed
    1. Sinico RA, Di Toma L, Radice A: Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 12: 477–482, 2013 - PubMed
    1. Watts RA, Mahr A, Mohammad AJ, Gatenby P, Basu N, Flores-Suárez LF: Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30[Suppl 1]: i14–i22, 2015 - PubMed
    1. Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez GA, Bozzolo EP, Monti S, Bracaglia C, Marucci G, Bodria M, Sinico RA, Pieruzzi F, Moroni G, Pastore S, Emmi G, Esposito P, Catanoso M, Barbano G, Bonanni A, Vaglio A: ANCA-associated vasculitis in childhood: Recent advances. Ital J Pediatr 43: 46, 2017 - PMC - PubMed
    1. Grisaru S, Yuen GW, Miettunen PM, Hamiwka LA: Incidence of Wegener’s granulomatosis in children. J Rheumatol 37: 440–442, 2010 - PubMed

Publication types

MeSH terms